General Information of the Compound
| Compound ID |
CP0518452
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2R,3R,4S,5R)-2-[6-amino-2-[(2E)-2-[(2E,4E)-deca-2,4-dienylidene]hydrazinyl]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H29N7O4
|
||||||||||||||||||
| Molecular Weight |
431.497
|
||||||||||||||||||
| Canonical SMILES |
CCCCC\C=C\C=C\C=N\Nc1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H29N7O4/c1-2-3-4-5-6-7-8-9-10-23-26-20-24-17(21)14-18(25-20)27(12-22-14)19-16(30)15(29)13(11-28)31-19/h6-10,12-13,15-16,19,28-30H,2-5,11H2,1H3,(H3,21,24,25,26)/b7-6+,9-8+,23-10+/t13-,15-,16-,19-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LCYPSICJTNPPEJ-LIJLLEJISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a